We are live on ! Find out more
DMIIR icon

Drugs Made In America Acquisition II Corp Right
DMIIR

64 hedge funds and large institutions have $2.71M invested in Drugs Made In America Acquisition II Corp Right in 2026 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

541% more capital inflows, than outflows

Capital inflows: $273K | Capital outflows: $42.6K

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

3% more funds holding

Funds holding: 62 → 64 (+2)

44% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 9

Holders
64
Holders Change
+2
Holders Change %
+3.23%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
9
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

DMIIR Hedge Fund Activity: Q3 2026 in Review

64 of the 8,227 institutional investors tracked by Wall St. Rank reported a position in Drugs Made In America Acquisition II Corp Right (DMIIR) for Q3 2026, worth a combined $2.71M — down 18% from $3.31M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new DMIIR positions and 1 closed out — a net gain of 4 holders — while 5 added to existing stakes and 9 trimmed.

The largest buyer was LMR Partners, opening a new position worth an estimated $156K. The largest seller was Hudson Bay Capital Management, cutting an estimated $17.3K.

  • 64 institutional investors held Drugs Made In America Acquisition II Corp Right (DMIIR) as of Q3 2026, up from 62 in Q2 2026.
  • Funds reported $2.71M of Drugs Made In America Acquisition II Corp Right stock for Q3 2026, down 18% quarter-over-quarter.
  • 5 funds opened new Drugs Made In America Acquisition II Corp Right positions in Q3 2026 and 1 closed out, a net change of +4 holders.
  • The largest Drugs Made In America Acquisition II Corp Right buyer in Q3 2026 was LMR Partners, an estimated $156K added.
  • The largest Drugs Made In America Acquisition II Corp Right seller in Q3 2026 was Hudson Bay Capital Management, an estimated $17.3K sold.

Based on aggregated 13F filings for Q3 2026.